Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951

British Journal of Haematology

Volumn 152, Issue 4, 2011, Pages 441-451

  Ducassou, Stéphane ^a,b   Ferlay, Céline ^c   Bergeron, Christophe ^a   Girard, Sandrine ^d   Laureys, Geneviève ^e   Pacquement, Hélène ^f   Plantaz, Dominique ^g   Lutz, Patrick ^b   Vannier, Jean Pierre ^h   Uyttebroeck, Anna ⁱ   Bertrand, Yves ^a,j  

^a IHOP   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

^c CENTRE LÉON BÉRARD   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

^f INSTITUT CURIE   (France)

^g GRENOBLE UNIVERSITY HOSPITAL   (France)

^h ROUEN UNIVERSITY HOSPITAL   (France)

ⁱ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^j UNIVERSITÉ LYON 1   (France)

more..

Author keywords

Children; Lymphoblastic lymphoma; Precursor B cell

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; TIOGUANINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; B CELL LYMPHOMA; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL FEATURE; CONTINUOUS INFUSION; DEATH; DRUG MEGADOSE; EVENT FREE SURVIVAL; FEMALE; HUMAN; INFANT; LYMPHOBLASTOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OVERALL SURVIVAL; PRECURSOR B CELL LYMPHOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SURVIVAL RATE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; NEOPLASM STAGING; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RECURRENCE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 78851471897     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08541.x     Document Type: Article

References (31)

1. Anderson, J.R., Wilson, J.F., Jenkin, D.T., Meadows, A.T., Kersey, J., Chilcote, R.R., Coccia, P., Exelby, P., Kushner, J., Siegel, S. & Hammond, D. (1983) Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). New England Journal of Medicine, 308, 559-565.
2. Anderson, J.R., Jenkin, R.D., Wilson, J.F., Kjeldsberg, C.R., Sposto, R., Chilcote, R.R., Coccia, P.F., Exelby, P.R., Siegel, S., Meadows, A.T. & Denman Hammond, G. (1993) Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group. Journal of Clinical Oncology, 11, 1024-1032.
3. Bergeron, C., Pacquement, H., Perel, Y., Coze, C., Gandemer, V., Vannier, J.P., Mechinaud, F., Schmitt, C., Leverger, G., Baruchel, A. & Patte, C. (2005) Treatment of childhood T cell lymphoblastic lymphoma (TLL), results of the SFOP LMT96. Blood (ASH Annual Meeting Abstracts), 106, 1.
4. Bertrand, Y., Benoit, Y., Robert, A., Nelken, B., Uyttebroeck, A., Lutz, P., Ferster, A., Baruchel, A., Norton, L., Margueritte, G., Rohrlich, P., Munzer, M., Plantaz, D., Millot, F., Boutard, P., Sirvent, N., Hoyoux, C., Baila, L. & Otten, J. (2008) Dexamethasone(DEX)(6mg/sm/d) and Prednisolone(PRED)(60mg/sm/d) in induction therapy of childhood ALL are equally effective: results of the 2nd interim analysis of EORTC Trial 58951. Blood (ASH Annual Meeting Abstracts), 112, 1.
5. Burkhardt, B., Zimmermann, M., Oschlies, I., Niggli, F., Mann, G., Parwaresch, R., Riehm, H., Schrappe, M. & Reiter, A. (2005) The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. British Journal of Haematology, 131, 39-49.
6. Burkhardt, B., Woessmann, W., Zimmermann, M., Kontny, U., Vormoor, J., Doerffel, W., Mann, G., Henze, G., Niggli, F., Ludwig, W.D., Janssen, D., Riehm, H., Schrappe, M. & Reiter, A. (2006) Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. Journal of Clinical Oncology, 24, 491-499.
7. Burkhardt, B., Reiter, A., Landmann, E., Lang, P., Lassay, L., Dickerhoff, R., Lakomek, M., Henze, G. & von Stackelberg, A. (2009) Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group. Journal of Clinical Oncology, 27, 3363-3369.
8. Coustan-Smith, E., Sandlund, J.T., Perkins, S.L., Chen, H., Chang, M., Abromowitch, M. & Campana, D. (2009) Minimal disseminated disease in childhood T-cell lymphoblastic lymphoma: a report from the children's oncology group. Journal of Clinical Oncology, 27, 3533-3539.
9. Duval, M., Suciu, S., Ferster, A., Rialland, X., Nelken, B., Lutz, P., Benoit, Y., Robert, A., Manel, A.M., Vilmer, E., Otten, J. & Philippe, N. (2002) Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial. Blood, 99, 2734-2739.
10. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K.C., Grogan, T.M., Isaacson, P.G., Knowles, D.M., Mason, D.Y., Muller-Hermelink, H.K., Piler, S.A., Piris, M.A., Ralfkiaer, E. & Warnke, R.A. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
11. Iyengar, P., Ismiil, N. & Deodhare, S. (2004) Precursor B-cell lymphoblastic lymphoma of the ovaries: an immunohistochemical study and review of the literature. International Journal of Gynecological Pathology, 23, 193-197.
12. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
13. Lin, P., Jones, D., Dorfman, D.M. & Medeiros, L.J. (2000) Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement. American Journal of Surgical Pathology, 24, 1480-1490.
14. Link, M.P., Shuster, J.J., Donaldson, S.S., Berard, C.W. & Murphy, S.B. (1997) Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. New England Journal of Medicine, 337, 1259-1266.
15. Lones, M.A., Perkins, S.L., Sposto, R., Tedeschi, N., Kadin, M.E., Kjeldsberg, C.R., Wilson, J.F., Zwick, D.L. & Cairo, M.S. (2002) Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report. Journal of Clinical Oncology, 20, 2293-2301.
16. Mitsui, T., Mori, T., Fujita, N., Inada, H., Horibe, K. & Tsurusawa, M. (2009) Retrospective analysis of relapsed or primary refractory childhood lymphoblastic lymphoma in Japan. Pediatric Blood and Cancer, 52, 591-595.
17. Muljono, A., Graf, N.S. & Arbuckle, S. (2009) Primary cutaneous lymphoblastic lymphoma in children: series of eight cases with review of the literature. Pathology, 41, 223-228.
18. Murphy, S.B. (1980) Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Seminars in Oncology, 7, 332-339.
19. Neth, O., Seidemann, K., Jansen, P., Mann, G., Tiemann, M., Ludwig, W.D., Riehm, H. & Reiter, A. (2000) Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90. Medical and Pediatric Oncology, 35, 20-27.
20. Ozdemirli, M., Fanburg-Smith, J.C., Hartmann, D.P., Shad, A.T., Lage, J.M., Magrath, I.T., Azumi, N., Harris, N.L., Cossman, J. & Jaffe, E.S. (1998) Precursor B-Lymphoblastic lymphoma presenting as a solitary bone tumor and mimicking Ewing's sarcoma: a report of four cases and review of the literature. American Journal of Surgical Pathology, 22, 795-804.
21. Peto, R., Pike, M.C., Armitage, P., Breslow, N.E., Cox, D.R., Howard, S.V., Mantel, N., McPherson, K., Peto, J. & Smith, P.G. (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. British Journal of Cancer, 35, 1-39.
22. Pui, C.H. & Evans, W.E. (1998) Acute lymphoblastic leukemia. New England Journal of Medicine, 339, 605-615.
23. Reiter, A., Schrappe, M., Parwaresch, R., Henze, G., Muller-Weihrich, S., Sauter, S., Sykora, K.W., Ludwig, W.D., Gadner, H. & Riehm, H. (1995) Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage - a report of the Berlin-Frankfurt-Munster Group. Journal of Clinical Oncology, 13, 359-372.
24. Riehm, H., Gadner, H., Henze, G., Kornhuber, B., Lampert, F., Niethammer, D., Reiter, A. & Schellong, G. (1990) Results and significance of six randomized trials in four consecutive ALL-BFM studies. Haematol Blood Transfusion, 33, 439-450.
25. Sander, C.A., Jaffe, E.S., Gebhardt, F.C., Yano, T. & Medeiros, L.J. (1992) Mediastinal lymphoblastic lymphoma with an immature B-cell immunophenotype. American Journal of Surgical Pathology, 16, 300-305.
26. Sandlund, J.T., Pui, C.H., Zhou, Y., Behm, F.G., Onciu, M., Razzouk, B.I., Hijiya, N., Campana, D., Hudson, M.M. & Ribeiro, R.C. (2009) Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study. Leukemia, 23, 1127-1130.
27. Soslow, R.A., Baergen, R.N. & Warnke, R.A. (1999) B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology. Cancer, 85, 2648-2654.
28. Uyttebroeck, A., Suciu, S., Laureys, G., Robert, A., Pacquement, H., Ferster, A., Marguerite, G., Mazingue, F., Renard, M., Lutz, P., Rialland, X., Mechinaud, F., Cave, H., Baila, L. & Bertrand, Y. (2008) Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial. European Journal of Cancer, 44, 840-846.
29. Vilmer, E., Suciu, S., Ferster, A., Bertrand, Y., Cave, H., Thyss, A., Benoit, Y., Dastugue, N., Fournier, M., Souillet, G., Manel, A.M., Robert, A., Nelken, B., Millot, F., Lutz, P., Rialland, X., Mechinaud, F., Boutard, P., Behar, C., Chantraine, J.M., Plouvier, E., Laureys, G., Brock, P., Uyttebroeck, A., Margueritte, G., Plantaz, D., Norton, L., Francotte, N., Gyselinck, J., Waterkeyn, C., Solbu, G., Philippe, N. & Otten, J. (2000) Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group. Leukemia, 14, 2257-2266.
30. van der Werff Ten Bosch, J., Suciu, S., Thyss, A., Bertrand, Y., Norton, L., Mazingue, F., Uyttebroeck, A., Lutz, P., Robert, A., Boutard, P., Ferster, A., Plouvier, E., Maes, P., Munzer, M., Plantaz, D., Dresse, M.F., Philippet, P., Sirvent, N., Waterkeyn, C., Vilmer, E., Philippe, N. & Otten, J. (2005) Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG. Leukemia, 19, 721-726.
31. Wolff, J.E., Kortmann, R.D., Wolff, B., Pietsch, T., Peters, O., Schmid, H.J., Rutkowski, S., Warmuth-Metz, M. & Kramm, C. (2010) High dose methotrexate for pediatric high grade glioma: results of the HIT-GBM-D Pilot study. Journal of Neuro-Oncology, e-pub ahead of print; DOI.